Study · Case report or series · n = 1 · 2008

1 result

Male anorgasmia treated with oxytocin.

IsHak WW, Berman DS, Peters A

The journal of sexual medicine14 Dec 2007Cited by 36 (Europe PMC)

PMID18086171DOI10.1111/j.1743-6109.2007.00691.xPepBankPUB-18086171

Publisher page PubMedAsk about this study

Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

01HumanCase report or seriesEfficacy outcome
In one man with treatment-resistant anorgasmia, intranasal oxytocin given during intercourse restored ejaculation.
In plain wordsIn one man with treatment-resistant anorgasmia, oxytocin nasal spray restored ejaculation. This is a single case.
Peptide
Oxytocin
Outcome
IncreaseRestoration of ejaculation in male anorgasmia
Study
n = 1
Outcome group
Sexual function · Reproductive and sexual health
Studied dose
Dose not stated · intranasalAs given in this study (human).
Source sentences
Summary
Oxytocin was effective in restoring ejaculation.
1 context sentence(design, population, supporting numbers)
Summary · context
Oxytocin was administered using a nasal spray intracoitally because of its ultra-short half-life.
Report a problemFND-1808617101

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
11 Oct 2026, 01:30 UTC
Study results updated
Version 1
9 Oct 2026, 02:50 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

MeSH terms

PepBank is a research reference. Talk to a doctor before you use any peptide.